HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation (Q46987217)

27 December 2017

title

HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation (English)

1 reference

27 December 2017

author name string

Ho VT

1

1 reference

27 December 2017

Kim HT

2

1 reference

27 December 2017

Liney D

3

1 reference

27 December 2017

Milford E

4

1 reference

27 December 2017

Gribben J

5

1 reference

27 December 2017

Cutler C

6

1 reference

27 December 2017

Lee SJ

7

1 reference

27 December 2017

Antin JH

8

1 reference

27 December 2017

Soiffer RJ

9

1 reference

27 December 2017

Alyea EP

10

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

27 December 2017

Bone Marrow Transplantation

published in

1 reference

27 December 2017

volume

37

1 reference

27 December 2017

issue

9

1 reference

27 December 2017

page(s)

845-850

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705315

exact match

0 references

cites work

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

inferred from DOI database lookup

7 January 2021

based on heuristic

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705315

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1705315

1 reference

27 December 2017

1 reference

27 December 2017